These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10869949)

  • 1. Results with the Novacor assist system and evaluation of long-term assistance.
    Di Bella I; Pagani F; Banfi C; Ardemagni E; Capo A; Klersy C; Viganò M
    Eur J Cardiothorac Surg; 2000 Jul; 18(1):112-6. PubMed ID: 10869949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system.
    Vetter HO; Kaulbach HG; Schmitz C; Forst A; Uberfuhr P; Kreuzer E; Pfeiffer M; Brenner P; Dewald O; Reichart B
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):74-80. PubMed ID: 7815810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study.
    El-Banayosy A; Arusoglu L; Kizner L; Tenderich G; Minami K; Inoue K; Körfer R
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):581-7. PubMed ID: 10694620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance.
    Chen JM; Spanier TB; Gonzalez JJ; Marelli D; Flannery MA; Tector KA; Cullinane S; Oz MC
    J Heart Lung Transplant; 1999 Apr; 18(4):351-7. PubMed ID: 10226900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients.
    Nabavi DG; Stockmann J; Schmid C; Schneider M; Hammel D; Scheld HH; Ringelstein EB
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):160-7. PubMed ID: 12878951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Nippon-Zeon pneumatic ventricular assist device as a bridge to cardiac transplantation.
    Deleuze PH; Le Besnerais P; Mazzucotellu JP; Abe Y; Miyama M; Mourtada A; Benvenuti C; Loisance DY
    ASAIO J; 1994; 40(3):M325-8. PubMed ID: 8555533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Zimpfer D; Zrunek P; Sandner S; Schima H; Grimm M; Zuckermann A; Wolner E; Wieselthaler G
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):698-702. PubMed ID: 17289396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement.
    Loebe M; Hennig E; Müller J; Spiegelsberger S; Weng Y; Hetzer R
    Eur J Cardiothorac Surg; 1997 Apr; 11 Suppl():S18-24. PubMed ID: 9271176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of heart-, lung-, and liver-performance during mechanical circulatory support by the Novacor-system.
    Roell W; Goedje O; Vetter HO; Schmitz C; Dewald O; Reichart B
    Eur J Cardiothorac Surg; 1997 Jun; 11(6):1045-51. PubMed ID: 9237585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.
    Slaughter MS; Sobieski MA; Gallagher C; Dia M; Silver MA
    Tex Heart Inst J; 2008; 35(3):245-9. PubMed ID: 18941649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices.
    Oz MC; Rose EA; Slater J; Kuiper JJ; Catanese KA; Levin HR
    J Am Coll Cardiol; 1994 Dec; 24(7):1688-91. PubMed ID: 7963116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.